TrialThe Journal of clinical endocrinology and metabolism2020

Phase 3 Trial of a Small-volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty.

Karen O Klein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.